Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals

Introduction Multiple studies have shown the efficacy of the new direct-acting antivirals (DAAs) with a cure rate of over 90% in hepatitis C virus (HCV)-infected patients. Some recently published studies have suggested an increased incidence of de novo and recurrent hepatocellular carcinoma (HCC) in...

Descripción completa

Detalles Bibliográficos
Autores principales: Syed, Taseen, Fazili, Javid, Ali, Ijlal Akbar, Zhao, Daniel, Hughes, Diane, Mahmood, Sultan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166920/
https://www.ncbi.nlm.nih.gov/pubmed/30280052
http://dx.doi.org/10.7759/cureus.2843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166920/
https://www.ncbi.nlm.nih.gov/pubmed/30280052
http://dx.doi.org/10.7759/cureus.2843

Ejemplares similares